1. Home
  2. AIMD vs LDWY Comparison

AIMD vs LDWY Comparison

Compare AIMD & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • LDWY
  • Stock Information
  • Founded
  • AIMD 1984
  • LDWY 1990
  • Country
  • AIMD United States
  • LDWY United States
  • Employees
  • AIMD N/A
  • LDWY N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • LDWY Advertising
  • Sector
  • AIMD Health Care
  • LDWY Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • AIMD 16.9M
  • LDWY 9.2M
  • IPO Year
  • AIMD N/A
  • LDWY 1991
  • Fundamental
  • Price
  • AIMD $3.40
  • LDWY $5.15
  • Analyst Decision
  • AIMD
  • LDWY
  • Analyst Count
  • AIMD 0
  • LDWY 0
  • Target Price
  • AIMD N/A
  • LDWY N/A
  • AVG Volume (30 Days)
  • AIMD 89.6K
  • LDWY 5.5K
  • Earning Date
  • AIMD 11-05-2025
  • LDWY 08-28-2025
  • Dividend Yield
  • AIMD N/A
  • LDWY N/A
  • EPS Growth
  • AIMD N/A
  • LDWY N/A
  • EPS
  • AIMD N/A
  • LDWY 1.66
  • Revenue
  • AIMD $110,870.00
  • LDWY $71,244,000.00
  • Revenue This Year
  • AIMD N/A
  • LDWY N/A
  • Revenue Next Year
  • AIMD N/A
  • LDWY N/A
  • P/E Ratio
  • AIMD N/A
  • LDWY $3.03
  • Revenue Growth
  • AIMD 70.25
  • LDWY 187.12
  • 52 Week Low
  • AIMD $2.00
  • LDWY $3.02
  • 52 Week High
  • AIMD $5.00
  • LDWY $6.19
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 48.33
  • LDWY 45.96
  • Support Level
  • AIMD $3.28
  • LDWY $4.64
  • Resistance Level
  • AIMD $3.83
  • LDWY $5.35
  • Average True Range (ATR)
  • AIMD 0.28
  • LDWY 0.33
  • MACD
  • AIMD -0.06
  • LDWY -0.07
  • Stochastic Oscillator
  • AIMD 12.64
  • LDWY 32.90

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: